Our subsequent investigations discovered that certain constituents of CSP may exert regulatory control over LXRα (Zhao et al., 2019; Wu et al., 2022), but it remains unknown whether CSP improves MS-related IR by regulating LXRα. This evidence concerns the gene DNAJC5 and myeloid sarcoma.